Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation
Michael Roth(The University of Texas MD Anderson Cancer Center), Ulrich Steidl(Albert Einstein College of Medicine), Laura Barreyro(Albert Einstein College of Medicine), Boris Bartholdy(Albert Einstein College of Medicine), Britta Will(Albert Einstein College of Medicine), G Simkin(Albert Einstein College of Medicine), Roni Tamari(Memorial Sloan Kettering Cancer Center), Constantine S. Mitsiades(Beth Israel Deaconess Medical Center), Swathi Narayanagari(Albert Einstein College of Medicine), Amit Verma(Albert Einstein College of Medicine)
Cited by 167
Related Papers
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications
|Proceedings of the National Academy of Sciences|2003|531
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
|Scientific Reports|2016|263
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach
|CA A Cancer Journal for Clinicians|2022|251
Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma
|Cancer|2013|157
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
|Biology of Blood and Marrow Transplantation|2015|142